Kurono Sadamu, Kaneko Yuka, Matsuura Nariaki, Oishi Haruki, Noguchi Shinzaburo, Kim Seung Jin, Tamaki Yasuhiro, Aikawa Takao, Kotsuma Yoshikazu, Inaji Hideo, Matsuura Shuji
Laboratory of Molecular Signature Analysis, Division of Health Sciences, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Laboratory Chemicals Division, Wako Pure Chemical Industries, Ltd, Osaka, Japan.
Proteomics Clin Appl. 2016 May;10(5):605-13. doi: 10.1002/prca.201500016. Epub 2016 Apr 26.
This research aimed to establish a diagnostic technique for breast cancer using nipple discharge (ND), with the objective of preventive diagnosis. ND has been proposed as a source of secreted proteomes that reflect early pathological changes in the ductal-lobular epithelial microenvironment, and could thus provide breast-specific cancer biomarkers that could be accessed noninvasively as a new clinical diagnostic technique.
Minute amounts of ND from patients with and without breast cancer (n = 19 and 12, respectively) were collected at the hospital and kept frozen until just before use. They were analyzed using high-pH RP peptide fractionations/low-pH RP 2D nano-LC/ESI-MS/MS. Biomarker candidates were also investigated using Western blot analysis and sandwich ELISA on ND and/or sera.
We found distinct tendencies in protein expression and three candidate breast cancer biomarkers (carbonic anhydrase 2, catalase, and peroxiredoxin-2) whose levels differed significantly between ND specimens from patients with and without breast cancer.
These tendencies in protein expression and markers provide new ways to identify breast cancer patients. Therefore, RP/RP 2D LC/MS/MS analyses of ND and the above three markers are supported as a new breast cancer diagnostic technique.
本研究旨在建立一种利用乳头溢液(ND)诊断乳腺癌的技术,以实现预防性诊断。乳头溢液已被认为是分泌蛋白质组的来源,可反映导管 - 小叶上皮微环境的早期病理变化,因此有可能提供乳腺特异性癌症生物标志物,作为一种新的临床诊断技术可通过非侵入性方式获取。
在医院收集了微量的乳腺癌患者和非乳腺癌患者的乳头溢液(分别为19例和12例),并冷冻保存直至使用前。采用高pH反相肽分级分离/低pH反相二维纳升液相色谱/电喷雾串联质谱对其进行分析。还通过蛋白质印迹分析以及对乳头溢液和/或血清进行夹心酶联免疫吸附测定来研究候选生物标志物。
我们发现了蛋白质表达的明显趋势以及三种候选乳腺癌生物标志物(碳酸酐酶2、过氧化氢酶和过氧化物酶2),其在乳腺癌患者和非乳腺癌患者的乳头溢液标本中的水平存在显著差异。
这些蛋白质表达趋势和标志物为识别乳腺癌患者提供了新方法。因此,支持将乳头溢液的反相/反相二维液相色谱/串联质谱分析以及上述三种标志物作为一种新的乳腺癌诊断技术。